Related Experiment Video
Updated: Jul 17, 2026

07:56
Scanning Skeletal Remains for Bone Mineral Density in Forensic Contexts
Published on: January 29, 2018
Effect of bone strontium on BMD measurements
1King's College London School of Medicine, London, UK. glen.blake@kcl.ac.uk
Summary
Strontium ranelate treatment for osteoporosis can overestimate bone mineral density (BMD) measurements. This study theoretically estimates this overestimation, providing a strontium ratio to correct BMD readings for accurate patient monitoring.
Area of Science:
- Biomedical Engineering
- Radiology
- Pharmacology
Background:
- Strontium ranelate is an osteoporosis treatment with a known effect on bone mineral density (BMD) measurements.
- Strontium's higher X-ray attenuation compared to calcium leads to overestimated BMD readings.
Purpose of the Study:
- To theoretically estimate the overestimation of BMD measurements caused by strontium substitution in bone.
- To calculate the strontium ratio for different X-ray absorptiometry techniques.
Main Methods:
- Utilized X-ray attenuation coefficients to calculate the strontium ratio (%Sr/[Ca+Sr]).
- Estimated the effect for axial dual-energy X-ray absorptiometry (DXA), peripheral DXA (pDXA), and single-energy quantitative computed tomography (SEQCT).
Main Results:
- Theoretical strontium ratios for DXA varied by device and effective photon energy (e.g., 9.0-10.8).
- SEQCT showed strontium ratios of 6.2 at 60 keV and 4.4 at 80 keV.
- Results align with previously reported experimental values for DXA systems.
Conclusions:
- A reliable strontium ratio is crucial for adjusting BMD measurements in patients treated with strontium ranelate.
- Accurate BMD adjustments are necessary for interpreting DXA scans, even after treatment discontinuation.
Related Concept Videos
Bone Disorders
Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Osteoclasts in Bone Remodeling
Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during bone...

